eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the close of a $191 million Series D financing....
eGenesis a biotechnology company developing human-compatible organs and cells to treat organ failure and focusing on therapeutic applications of isolated organ perfusion. Medical device...
